Gender and age modify the association between APOE and AD-related neuropathology

被引:84
作者
Ghebremedhin, E
Schultz, C
Thal, DR
Rüb, U
Ohm, TG
Braak, E
Braak, H
机构
[1] Univ Frankfurt, Dept Clin Neuroanat, D-60590 Frankfurt, Germany
[2] Humboldt Univ, Fac Med Charite, Dept Anat, Berlin, Germany
关键词
D O I
10.1212/WNL.56.12.1696
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To assess the impact of apolipoprotein E (APOE) polymorphism on AD-related neurofibrillary tangle (NFT) formation and senile plaques (SP). Methods: A sample of 729 routine autopsy brains (359 men, 370 women; age range, 60 to 99 years) was investigated. All brains were classified neuropathologically according to a procedure permitting differentiation of six NFT stages and three SP stages. APOE genotyping was performed on all cases. Results: The epsilon4 allele of APOE was associated not only with SP (p < 0.0001) but also with NFT formation (p < 0.0001). The effect of the epsilon4 allele on NFT formation was noted at ages greater than or equal to 80 years (p < 0.0001) but not between ages 60 and 79 years (p = 0.12). An association between the <epsilon>4 allele and SP for women was found at ages 60 to 79 years (p < 0.0001) but not at <greater than or equal to>80 years of age (p = 0.063). By comparison, men showed an association in both age categories (p = 0.001 and p = 0.001). Conclusion: The results confirm the association between the epsilon4 allele and both typos of AD-related lesions and show that this association is differentially modified by age and gender.
引用
收藏
页码:1696 / 1701
页数:6
相关论文
共 36 条
[1]   Frequency of stages of Alzheimer-related lesions in different age categories [J].
Braak, H ;
Braak, E .
NEUROBIOLOGY OF AGING, 1997, 18 (04) :351-357
[2]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[3]   Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections [J].
Braak, Heiko ;
Braak, Eva .
BRAIN PATHOLOGY, 1991, 1 (03) :213-216
[4]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[5]   Alzheimer's disease: Interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset [J].
Duara, R ;
Barker, WW ;
LopezAlberola, R ;
Loewenstein, DA ;
Grau, LB ;
Gilchrist, D ;
Sevush, S ;
StGeorgeHyslop, PH .
NEUROLOGY, 1996, 46 (06) :1575-1579
[6]   Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease - A meta-analysis [J].
Farrer, LA ;
Cupples, LA ;
Haines, JL ;
Hyman, B ;
Kukull, WA ;
Mayeux, R ;
Myers, RH ;
PericakVance, MA ;
Risch, N ;
vanDuijn, CM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (16) :1349-1356
[7]   Improved method facilitates reliable APOE genotyping of genomic DNA extracted from formaldehyde-fixed pathology specimens [J].
Ghebremedhin, E ;
Braak, H ;
Braak, E ;
Sahm, J .
JOURNAL OF NEUROSCIENCE METHODS, 1998, 79 (02) :229-231
[8]   High frequency of apolipoprotein E ε4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes [J].
Ghebremedhin, E ;
Schultz, C ;
Braak, E ;
Braak, H .
EXPERIMENTAL NEUROLOGY, 1998, 153 (01) :152-155
[9]   Argyrophilic grain disease is associated with apolipoprotein E ε2 allele [J].
Ghebremedhin, E ;
Schultz, C ;
Botez, G ;
Rüb, U ;
Sassin, I ;
Braak, E ;
Braak, H .
ACTA NEUROPATHOLOGICA, 1998, 96 (03) :222-224
[10]   Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease [J].
GomezIsla, T ;
West, HL ;
Rebeck, GW ;
Harr, SD ;
Growdon, JH ;
Locascio, JJ ;
Perls, TT ;
Lipsitz, LA ;
Hyman, BT .
ANNALS OF NEUROLOGY, 1996, 39 (01) :62-70